Christopher & Banks Corp. (NYSE:CBK)’s share price shot up 8% during trading on Friday . The stock traded as high as $2.06 and last traded at $2.03, with a volume of 300,014 shares changing hands. The stock had previously closed at $1.88.

Several research firms have commented on CBK. Zacks Investment Research raised Christopher & Banks Corp. from a “hold” rating to a “buy” rating and set a $2.75 price target for the company in a report on Wednesday, June 15th. Dougherty & Co raised Christopher & Banks Corp. from a “neutral” rating to a “buy” rating and set a $3.25 price target for the company in a report on Thursday, April 7th. Finally, TheStreet cut Christopher & Banks Corp. from a “hold” rating to a “sell” rating in a report on Monday, April 11th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $4.00.

The company’s market capitalization is $75.28 million. The stock has a 50-day moving average price of $2.16 and a 200 day moving average price of $2.08.

A hedge fund recently raised its stake in Christopher & Banks Corp. stock. Russell Frank Co raised its position in Christopher & Banks Corp. (NYSE:CBK) by 1,350.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 716,742 shares of the company’s stock after buying an additional 667,340 shares during the period. Russell Frank Co owned 1.92% of Christopher & Banks Corp. worth $1,118,000 as of its most recent SEC filing.

Christopher & Banks Corporation is a national specialty retailer featuring private-brand women’s apparel and accessories. The Company offers its customers an assortment of clothing for everyday needs. Its merchandise assortments include designs of women’s apparel, generally consisting of casual clothing, everyday basics, wear-to-work, leisure/active wear, and sleepwear in missy, petite and women sizes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.